Cargando…
Monocyte Chemotactic Protein-1 Promotes the Myocardial Homing of Mesenchymal Stem Cells in Dilated Cardiomyopathy
Dilated cardiomyopathy (DCM) is the most common form of non-ischemic cardiomyopathy that leads to heart failure. Mesenchymal stem cells (MSCs) are under active investigation currently as a potential therapy for DCM. However, little information is available about the therapeutic potential of intraven...
Autores principales: | Guo, Jing, Zhang, Haifeng, Xiao, Junjie, Wu, Jian, Ye, Yong, Li, Zheng, Zou, Yunzeng, Li, Xinli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645736/ https://www.ncbi.nlm.nih.gov/pubmed/23591836 http://dx.doi.org/10.3390/ijms14048164 |
Ejemplares similares
-
Chemotactic response of monocytes to thrombin
Publicado: (1983) -
Endothelin-1 Stimulates Monocytes in vitro to Release
Chemotactic Activity Identified as Interleukin-8 and Monocyte Chemotactic Protein-1
por: Helset, E., et al.
Publicado: (1994) -
Myocardial remodelling and recovery in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017) -
Effects of stem cell therapy on dilated cardiomyopathy
por: Jiao, Rong, et al.
Publicado: (2014) -
Interferon-γ Stimulates Monocyte Chemotactic Protein-1 Expression by Monocytes
por: Liebler, J. M., et al.
Publicado: (1994)